Keerthana C K

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (3)

• Uttroside B, a US FDA-designated ‘Orphan Drug’, mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3
  Chenicheri Kizhakkeveettil Keerthana, Tennyson Prakash Rayginia, Kalimuthu Kalishwaralal

  +21 more

  • Sandhini Saha
  • Nair Hariprasad Haritha
  • Amrutha Nisthul A.
  • Mundanattu Swetha
  • Sreekumar Usha Devi Aiswarya
  • +16 more
  Cell Death Discovery 2026 DOI: 10.1038/s41420-026-03055-5
  +Save
• A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma
  Chenicheri Kizhakkeveettil Keerthana, Sreekumar Usha Devi Aiswarya, Tennyson Prakash Rayginia +8 more
  Anti-Cancer Agents in Medicinal Chemistry 2024 DOI: 10.2174/0118715206316190240527160242
  +Save
• The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment
  Frontiers in Immunology 2023 DOI: 10.3389/fimmu.2023.1114582
  +Save